← Evidence map

ArticleMolecular therapy oncolytics2022

PI3K-activated MSC proteomes inhibit mammary tumors via Hsp90ab1 and Myh9.

Xun Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36090473